Abstract
Dysregulated lipid metabolism is a prominent feature of prostate cancers. Two papers in this issue identify novel genomic drivers of lipid metabolism in prostate cancer and provide implications for the subtyping and treatment of the disease.
Original language | English |
---|---|
Pages (from-to) | 1-2 |
Journal | Nature Genetics |
DOIs | |
Publication status | Early online date - 15 Jan 2018 |
Keywords
- Journal Article